Although IL-2 expression was not directly repressed by tofacitinib in vitro, the heightened frequency of IL-2+ T cells in colitis-diseased mice was partly controlled by later, but less so by earlier, tofacitinib administration (Figure 6A). This evidence concerns the gene IL2 and colitis.